Glenmark Life Sciences IPO: Should You Subscribe? Strong Player In APIs With Focus On Contract Development and Manufacturing
Glenmark Pharma Begins Phase 3 Of Clinical Trials For Favipiravir, Potential COVID-19 Drug In India
